Public directory / Facility profile

Central Admixture Pharmacy Services, Phoenix

AZ · FDA-registered outsourcing facility (503B). A factual public-record profile built from FDA sources, with dates. It is not a ranking, grade, or endorsement.

What the public record shows

FDA 503B registration status

FDA 503B list ✓ (current 2026-07-14)

Central Admixture Pharmacy Services, Phoenix appears on FDA's registered outsourcing facilities list, parsed from Veritura's capture of that list (FDA list current as of 2026-07-14, captured 2026-07-17). Registration status can change between captures; the FDA page is the authoritative current source.

On our captures

On FDA's list since we began tracking captures on 2026-07-11 (tracking began 2026-07-10; we make no claim about FDA's list before our first capture). Last confirmed on our 2026-07-17 capture (FDA list current as of 2026-07-14).

Dates are Veritura's own capture dates of FDA's public list, shown next to FDA's list-current date wherever we have it. Public-record posture, not a determination.

FDA enforcement timeline

4 dated enforcement records matched this firm name in openFDA when this check last completed.

  • 2023-08-17 · drug · Class II · Terminated
    Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
  • 2023-08-17 · drug · Class II · Terminated
    Lack of Assurance of Sterility:Lack of validation data for sanitization cycles
  • 2023-07-14 · drug · Class II · Terminated
    Lack of assurance of sterility. Validation data for decontamination cycles is lacking.
  • 2023-07-14 · drug · Class II · Terminated
    Lack of assurance of sterility. Validation data for decontamination cycles is lacking.

Source: openFDA enforcement records (drug/device/food, updated weekly), checked 2026-07-18. Dated public records matching this firm name; similar firm names collide in public records, so confirm the firm identity against the source records before relying. Public-record posture, not a determination.

Live FDA enforcement screen

4 enforcement record matches on this firm name in openFDA when this screen last ran. Review the underlying public records and confirm the firm identity before relying on this signal.

0 FDA compliance action records matched this name.

Source: openFDA enforcement records and FDA compliance dashboards, refreshed at most every 6 hours. A count here documents what public sources returned for this name (searched: Central Admixture Pharmacy Services, Phoenix); it is not a Veritura determination about the facility.

Reported products

40 distinct products as reported to FDA in 503B product reports (data vintage: reporting periods 2025-2, 2025-1); 20 shown.

  • Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Calcium Gluconate Monohydrate; Heparin Sodium · .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL · solution · reported period 2025-2
  • Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Calcium Gluconate Monohydrate; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine · .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL; 125 U/250 mL; 3.75 meq/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL · solution · reported period 2025-2
  • Aspartic Acid; Glutamic Acid · 9.8 g/125 mL; 10.7 g/125 mL · solution · reported period 2025-2
  • Calcium Chloride; Sodium Chloride; Potassium Chloride; Mannitol; Lidocaine Hydrochloride; Sodium Bicarbonate · .105 g/522.8 mL; 2.743 g/522.8 mL; 3.672 g/522.8 mL; 31.26 g/522.8 mL; 250 mg/522.8 mL; .924 g/522.8 mL · solution · reported period 2025-2
  • Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium · 3.75 meq/250 mL; .3125 g/250 mL; .75 g/250 mL; .2375 g/250 mL; .0275 g/250 mL; .15 g/250 mL; .2625 g/250 mL; .015 g/250 mL; .3 g/250 mL; .75 g/250 mL; .01563 g/250 mL; 25 g/250 mL; .875 g/250 mL; .2125 g/250 mL; .425 g/250 mL; .2 g/250 mL; .5125 g/250 mL; .3375 g/250 mL; .225 g/250 mL; .3 g/250 mL; .125 g/250 mL; .4875 g/250 mL; 125 U/250 mL · solution · reported period 2025-2
  • Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Valine; Heparin Sodium · 3.75 meq/250 mL; .7 g/250 mL; .17 g/250 mL; .34 g/250 mL; .16 g/250 mL; 41 g/250 mL; .27 g/250 mL; .18 g/250 mL; .24 g/250 mL; .1 g/250 mL; .6 g/250 mL; .19 g/250 mL; .25 g/250 mL; .022 g/250 mL; .12 g/250 mL; .21 g/250 mL; .012 g/250 mL; .24 g/250 mL; .6 g/250 mL; .0125 g/250 mL; 25 g/250 mL; .39 g/250 mL; 125 U/250 mL · solution · reported period 2025-2
  • Calcium Gluconate Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Glutamic Acid; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate · 3.75 meq/250 mL; 1.4 g/250 mL; .34 g/250 mL; .68 g/250 mL; .32 g/250 mL; .82 g/250 mL; .54 g/250 mL; .36 g/250 mL; .48 g/250 mL; .2 g/250 mL; .78 g/250 mL; 125 U/250 mL; 1.2 g/250 mL; .38 g/250 mL; .5 g/250 mL; .044 g/250 mL; .24 g/250 mL; .42 g/250 mL; .024 g/250 mL; .48 g/250 mL; 1.2 g/250 mL; .025 g/250 mL; 25 g/250 mL · solution · reported period 2025-2
  • Citric Acid Monohydrate; Sodium Phosphate, Monobasic, Monohydrate; Anhydrous Dextrose; Sodium Chloride; Tromethamine; Potassium Chloride; Dextrose Monohydrate; Trisodium Citrate Dihydrate · 1.9947 g/1000 mL; 1.3542 g/1000 mL; 28.304 g/1000 mL; 27.2 meq/1000 mL; 4.428 g/1000 mL; 36 meq/1000 mL; 68.2 g/1000 mL; 16.043 g/1000 mL · solution · reported period 2025-2
  • Citric Acid Monohydrate; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Anhydrous Dextrose; Aspartic Acid; Glutamic Acid; Dextrose Monohydrate; Tromethamine · 3.67875 g/477.5 mL; 29.5875 g/477.5 mL; 2.4975 g/477.5 mL; 52.2 g/477.5 mL; 4.9 g/477.5 mL; 5.35 g/477.5 mL; 12.11 g/477.5 mL; 4.05 g/477.5 mL · solution · reported period 2025-2
  • Citric Acid Monohydrate; Trisodium Citrate Dihydrate; Sodium Phosphate, Monobasic, Monohydrate; Anhydrous Dextrose; Sodium Chloride; Tromethamine; Potassium Chloride; Dextrose Monohydrate · 1.635 g/810 mL; 13.15 g/810 mL; 1.11 g/810 mL; 23.2 g/810 mL; 18.8 meq/810 mL; 7.2 g/810 mL; 20 meq/810 mL; 49.45 g/810 mL · solution · reported period 2025-2
  • Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Glutamic Acid; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Heparin Sodium; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine · .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL; 125 U/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL · solution · reported period 2025-2
  • Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine · .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL · solution · reported period 2025-2
  • Diltiazem Hydrochloride · 125 mg/125 mL · solution · reported period 2025-2
  • Epinephrine · 2 mg/250 mL · solution · reported period 2025-2
  • Epinephrine · 4 mg/250 mL · solution · reported period 2025-2
  • Epinephrine · 8 mg/250 mL · solution · reported period 2025-2
  • Glutamic Acid; Aspartic Acid · 67.29 g/1000 mL; 60.3 g/1000 mL · solution · reported period 2025-2
  • Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Aspartic Acid; Leucine; Methionine; Proline; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium · .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; .24 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 2.33 meq/250 mL; 125 U/250 mL · solution · reported period 2025-2
  • Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine · .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 25 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL · solution · reported period 2025-2
  • Glutamic Acid; Lysine Acetate; Serine; Tyrosine; N-Acetyltyrosine; Threonine; Cysteine Hydrochloride; Histidine; Arginine; Taurine; Dextrose Monohydrate; Leucine; Methionine; Proline; Aspartic Acid; Isoleucine; Alanine; Glycine; Phenylalanine; Tryptophan; Valine; Calcium Gluconate Monohydrate; Heparin Sodium · .375 g/250 mL; .9 g/250 mL; .285 g/250 mL; .033 g/250 mL; .18 g/250 mL; .315 g/250 mL; .018 g/250 mL; .36 g/250 mL; .9 g/250 mL; .01875 g/250 mL; 12.5 g/250 mL; 1.05 g/250 mL; .255 g/250 mL; .51 g/250 mL; .24 g/250 mL; .615 g/250 mL; .405 g/250 mL; .27 g/250 mL; .36 g/250 mL; .15 g/250 mL; .585 g/250 mL; 3.75 meq/250 mL; 125 U/250 mL · solution · reported period 2025-2

Source: FDA outsourcing facility product reports (FD&C 503B(b)(2)). Retrospective by design: a row means the facility reported compounding this product to FDA in the named period, never that it currently compounds, can supply, or is endorsed for it. Public-record posture, not a determination.

Watch this facility

Get an email if this facility's FDA list status or enforcement record changes between our captures. Public-record change notices only; every email carries a one-click unsubscribe link.

Is this your facility?

Claim this profile to keep it accurate and attach your own documentation through Veritura. Every claim is verified by hand before anything changes.

Documented public status from FDA sources. Not an approval, ranking, or endorsement. Veritura does not rank facilities. Dates below show when FDA's list was current and when we captured it, not a Veritura verification of any facility.